Evaluation of Low-cost, Manual Techniques for Rapid Detection of Ceftazidime-avibactam Susceptibility against Carbapenem-Resistant Enterobacterales | ||||
| Egyptian Journal of Medical Microbiology | ||||
| Article 24, Volume 34, Issue 2, April 2025, Page 201-209 PDF (513.18 K) | ||||
| Document Type: New and original researches in the field of Microbiology. | ||||
| DOI: 10.21608/ejmm.2025.347909.1417 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Salah A.I. Ali1; Aya A. Ghamry  2; Alyaa M. El-Zayaat3; Fatma M.A. Alsayaad4; Fatma A. Ibrahim1
| ||||
| 1Clinical Pathology Department, Faculty of Medicine, Zagazig University, Sharqia, Egypt | ||||
| 2Medical Microbiology and Immunology Department, Faculty of Medicine (for Girls), Al-Azhar University, Cairo, Egypt | ||||
| 3Anesthesia, Intensive Care, and Pain management Department, Faculty of Medicine, Zagazig University, Sharqia, Egypt | ||||
| 4Internal Medicine Department, Faculty of Medicine, Zagazig University, Sharqia, Egypt | ||||
| Abstract | ||||
| Background: Ceftazidime-avibactam (CAZ–AVI) is a new effective therapeutic combination that exhibits exceptional efficacy against clinically significant serine β-lactam-resistant bacteria. Emergence of CAZ–AVI resistance has been observed in carbapenem-resistant Enterobacterales (CRE). Therefore, rapid and accurate detection of CAZ–AVI susceptibility is time-saving for clinical treatment measures. Objective: To assess the efficacy and usage in clinical setting of two low-cost, rapid simple manual methods for screening of CAZ-AVI activity against CRE, to restrict spread of diseases and drug resistance through the implementation of rapid infection control programs. Methodology: The susceptibility of CAZ-AVI among CRE isolates was assessed using Rapid CAZ/AVI NP and Rapid ResaCeftazidime-avibactam-Enterobacterales NP tests along with broth microdilution method (BMD). Vitek- 2 compact was utilized to identify CRE isolates and CAZ/AVI sensitivity using GN and AST cards and Gene-Xpert system was used to determine the type of carbapenemase encoding genes. Results: This study utilized a total of 93 CRE isolates. Rapid CAZ/AVI NP test enabled the detection of CRE susceptibility to CAZ/AVI within three hours, with an overall percent agreement (OPA) of 97.9%, 2.8% major errors (MEs) and 0% very major errors (VMEs). In contrast, Rapid ResaCeftazidime-avibactam Enterobacterales NP test can be interpreted after 4 hours with an OPA of 98.9%, 1.4% MEs and 0% VMEs. Conclusion: These screening manual tests were rapid, simple, straightforward and easily applicable in routine microbiology laboratories. These tests are anticipated to be valuable tools for rapid clinical screening of CAZ-AVI susceptibility after further optimization of the test conditions in the near future. | ||||
| Keywords | ||||
| Ceftazidime-avibactam susceptibility testing; CAZ–AVI resistance; Enterobacterales; CRE | ||||
|
Statistics Article View: 209 PDF Download: 48 |
||||
